PLYMOUTH, MICH., Oct. 26, 2017 – Mitral regurgitation affects more than 4 million Americans – nearly one in 10 people aged 75 or older. Currently the primary option for the disease is open-heart surgery, which holds extremely high risks for patients in this age group and can prevent treatment in many cases. Non-invasive methods are entering the market to address this need and physicians are recognizing the importance of pre-surgical planning for this complex disease. Entering their pre-market phase of development, Materialise is working with select U.S. and EU hospital partners to validate the importance of accurate 3D modeling to help physicians plan complex transcatheter mitral valve replacement & repair (TMVR/r) procedures.
At the Materialise headquarters in Leuven, Belgium, the new building will not only increase production space, but will provide an additional 5,500 m² of office space for the company’s expanding workforce, allowing Materialise to continue investing in its people, and continue to empower meaningful 3D printing applications. New co-creation and partner rooms will also enable Materialise to continue building strong partnerships with customers across industries. The building will be inaugurated by Louis Tobback, the mayor of Leuven, in an evening event which will include tours around the new building.
Materialise has today announced the acquisition of ACTech, a Germany-based leader in producing limited runs of highly complex cast metal parts. The transaction brings together the metal competencies of Materialise, a leading provider of additive manufacturing solutions and software, with those of ACTech into a comprehensive metal manufacturing offering.
Ørgreen introduces 12 new models using the most advanced 3D printing technology of its kind – in bespoke designer frames that fit any face, any lifestyle. Adding design as a key element to a cutting-edge platform called Yuniku, developed by Materialise and Hoya Vision Care Company.